Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.

Aubert O, Higgins S, Bouatou Y, Yoo D, Raynaud M, Viglietti D, Rabant M, Hidalgo L, Glotz D, Legendre C, Delahousse M, Shah N, Sis B, Campbell P, Mengel M, Jouven X, Duong Van Huyen JP, Lefaucheur C, Loupy A.

J Am Soc Nephrol. 2019 Mar 14. pii: ASN.2018070777. doi: 10.1681/ASN.2018070777. [Epub ahead of print]

PMID:
30872323
2.

Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.

Bouatou Y, Viglietti D, Pievani D, Louis K, Duong Van Huyen JP, Rabant M, Aubert O, Taupin JL, Glotz D, Legendre C, Loupy A, Lefaucheur C.

Am J Transplant. 2019 Feb 12. doi: 10.1111/ajt.15299. [Epub ahead of print]

PMID:
30748089
3.

Towards a precision medicine approach to positive crossmatch transplantation: Impact on response to therapy.

Loupy A, Bouatou Y, Aubert O.

Am J Transplant. 2019 Jan 31. doi: 10.1111/ajt.15271. [Epub ahead of print] No abstract available.

PMID:
30703855
4.

Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study.

Bouatou Y, Gayet Ageron A, Bernasconi E, Battegay M, Hoffmann M, Staehelin C, Merz L, Kovari H, Fux C, de Seigneux S, Calmy A; Swiss HIV Cohort Study.

Kidney Int Rep. 2018 May 8;3(5):1089-1099. doi: 10.1016/j.ekir.2018.04.014. eCollection 2018 Sep.

5.

Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial.

van Sandwijk MS, de Vries APJ, Bakker SJL, Ten Berge IJM, Berger SP, Bouatou YR, de Fijter JW, Florquin S, Homan van der Heide JJ, Idu MM, Krikke C, van der Pant KAMI, Reinders ME, Ringers J, van der Weerd NC, Bemelman FJ, Sanders JS.

Transplant Direct. 2018 May 15;4(6):e354. doi: 10.1097/TXD.0000000000000794. eCollection 2018 Jun.

6.

Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.

Bouquegneau A, Loheac C, Aubert O, Bouatou Y, Viglietti D, Empana JP, Ulloa C, Murad MH, Legendre C, Glotz D, Jackson AM, Zeevi A, Schaub S, Taupin JL, Reed EF, Friedewald JJ, Tyan DB, Süsal C, Shapiro R, Woodle ES, Hidalgo LG, O'Leary J, Montgomery RA, Kobashigawa J, Jouven X, Jabre P, Lefaucheur C, Loupy A.

PLoS Med. 2018 Jul 27;15(7):e1002637. doi: 10.1371/journal.pmed.1002637. eCollection 2018 Jul.

7.

Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection.

Viglietti D, Bouatou Y, Kheav VD, Aubert O, Suberbielle-Boissel C, Glotz D, Legendre C, Taupin JL, Zeevi A, Loupy A, Lefaucheur C.

Kidney Int. 2018 Oct;94(4):773-787. doi: 10.1016/j.kint.2018.03.015. Epub 2018 May 22.

PMID:
29801667
8.

Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.

Bouquegneau A, Loheac C, Aubert O, Bouatou Y, Viglietti D, Empana JP, Ulloa C, Murad MH, Legendre C, Glotz D, Jackson AM, Zeevi A, Schaub S, Taupin JL, Reed EF, Friedewald JJ, Tyan DB, Süsal C, Shapiro R, Woodle ES, Hidalgo LG, O'Leary J, Montgomery RA, Kobashigawa J, Jouven X, Jabre P, Lefaucheur C, Loupy A.

PLoS Med. 2018 May 25;15(5):e1002572. doi: 10.1371/journal.pmed.1002572. eCollection 2018 May. Erratum in: PLoS Med. 2018 Jul 27;15(7):e1002637.

9.

Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective study.

Bouatou Y, Seyde O, Moll S, Martin PY, Villard J, Ferrari-Lacraz S, Hadaya K.

BMC Nephrol. 2018 Apr 12;19(1):86. doi: 10.1186/s12882-018-0886-5.

10.

Recipient rs1045642 Polymorphism Is Associated With Office Blood Pressure at 1-Year Post Kidney Transplantation: A Single Center Pharmacogenetic Cohort Pilot Study.

Bouatou Y, Stenz L, Ponte B, Ferrari S, Paoloni-Giacobino A, Hadaya K.

Front Pharmacol. 2018 Mar 5;9:184. doi: 10.3389/fphar.2018.00184. eCollection 2018.

11.

Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunction.

Wei FF, Trenson S, Monney P, Yang WY, Pruijm M, Zhang ZY, Bouatou Y, Huang QF, Ponte B, Martin PY, Thijs L, Kuznetsova T, Allegaert K, Janssens S, Vermeer C, Verhamme P, Burnier M, Bochud M, Ehret G, Staessen JA.

PLoS One. 2018 Mar 12;13(3):e0193967. doi: 10.1371/journal.pone.0193967. eCollection 2018.

12.

[Nephrology].

De Seigneux S, Ponte B, Hadaya K, Bouatou Y, Saudan P.

Rev Med Suisse. 2018 Jan 10;14(588-589):54-57. French.

PMID:
29337451
13.

Aryl hydrocarbon receptor expression by macrophages and lymphocytes within infiltrates in BK polyomavirus associated nephropathy.

Bouatou Y, Stokman G, Claessen N, Roelofs JJTH, Bemelman F, Kers J, Florquin S.

Transpl Immunol. 2018 Apr;47:18-21. doi: 10.1016/j.trim.2017.12.005. Epub 2018 Jan 2.

14.

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.

Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, van Huyen JPD, Gibson IW, Kraus ES, Mannon RB, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M.

Am J Transplant. 2018 Feb;18(2):293-307. doi: 10.1111/ajt.14625. Epub 2018 Jan 21.

15.

A population-based approach to assess the heritability and distribution of renal handling of electrolytes.

Moulin F, Ponte B, Pruijm M, Ackermann D, Bouatou Y, Guessous I, Ehret G, Bonny O, Pechère-Bertschi A, Staessen JA, Paccaud F, Martin PY, Burnier M, Vogt B, Devuyst O, Bochud M.

Kidney Int. 2017 Dec;92(6):1536-1543. doi: 10.1016/j.kint.2017.06.020. Epub 2017 Sep 6.

PMID:
28888328
16.

Diagnostic accuracy of immunofluorescence versus immunoperoxidase staining to distinguish immune complex-mediated glomerulonephritis and C3 dominant glomerulopathy.

Bouatou Y, Kers J, Chevalier-Florquin MSN, Claessen N, Nguyen TQ, Damman J, Proença H, Roelofs JJTH, Florquin S.

Histopathology. 2018 Mar;72(4):601-608. doi: 10.1111/his.13385. Epub 2017 Dec 22.

PMID:
28881045
17.

[Biopsy transcriptome in kidney transplantation : ready for primetime ?]

Bouatou Y, Hadaya K.

Rev Med Suisse. 2017 Feb 22;13(551):457-461. French.

PMID:
28714646
18.

Nephrotic Syndrome in Small Cell Lung Cancer and Induction of C-Mip in Podocytes.

Bouatou Y, Koessler T, Oniszczuk J, Zhang SY, Moll S, Audard V, de Seigneux S, Sahali D.

Am J Kidney Dis. 2017 Mar;69(3):477-480. doi: 10.1053/j.ajkd.2016.09.026. Epub 2017 Jan 4.

PMID:
28063735
19.

Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".

Bouatou Y, El Biali M, Samer CF.

Circulation. 2016 Jul 12;134(2):e3-4. doi: 10.1161/CIRCULATIONAHA.116.022034. No abstract available.

PMID:
27400900
20.

[Genetic kidney diseases: new perspectives on diagnosis].

Bouatou Y, Paoloni-Giacobino A, Parvex P, De Seigneux S.

Rev Med Suisse. 2016 Feb 24;12(507):387-8, 390-2. Review. French.

PMID:
27039603
21.

Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review.

Bouatou Y, Samer CF, Fontana P, Daali Y, Desmeules J.

Curr Drug Metab. 2015;16(2):97-104. Review.

PMID:
26179606
22.

[Nephrology: news in renal transplantation].

Bouatou Y, Hadaya K.

Rev Med Suisse. 2015 Jan 14;11(456-457):87-90. French.

PMID:
25799658
23.

Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial Presentation.

Bouatou Y, Bacchi VF, Villard J, Moll S, Martin PY, Hadaya K.

Transplant Direct. 2015 Mar 26;1(2):e9. doi: 10.1097/TXD.0000000000000518. eCollection 2015 Mar.

24.

ABO incompatible kidney transplantation from an anti-hepatitis C virus antibody-positive RNA-negative donor into an anti-hepatitis C virus antibody-negative recipient.

Bouatou Y, Negro F, Hadaya K.

Transpl Int. 2015 Jan;28(1):127-8. doi: 10.1111/tri.12427. Epub 2014 Oct 12. No abstract available.

25.

Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity.

Bouatou Y, Samer CF, Ing Lorenzini KR, Daali Y, Daou S, Fathi M, Rebsamen M, Desmeules J, Calmy A, Escher M.

AIDS Res Ther. 2014 Aug 4;11:25. doi: 10.1186/1742-6405-11-25. eCollection 2014.

26.

[Use of antiplatelet agents in patients with chronic kidney disease: what is the evidence?].

Gabrielli A, Bouatou Y, Saudan P.

Rev Med Suisse. 2014 Feb 26;10(419):487-90, 492. Review. French.

PMID:
24665658
27.

Carbimazole-induced, ANCA-associated, crescentic glomerulonephritis: case report and literature review.

Mavrakanas TA, Bouatou Y, Samer C, de Seigneux S, Meyer P.

Ren Fail. 2013;35(3):414-7. doi: 10.3109/0886022X.2012.760356. Epub 2013 Jan 24. Review.

PMID:
23343442

Supplemental Content

Loading ...
Support Center